Taylor & Francis Group
Browse
tbbb_a_1659721_sm2662.docx (440.22 kB)

Dietary supplementation of a high-temperature-processed green tea extract attenuates cognitive impairment in PS2 and Tg2576 mice

Download (440.22 kB)
journal contribution
posted on 2019-08-29, 07:35 authored by Juewon Kim, Shinichiro Funayama, Naotaka Izuo, Takahiko Shimizu

Green tea intake is generally recognized as an effective supplement that promotes mental clarity and cognitive function. These health benefits of green tea have been attributed mainly to its effective component, epigallocatechin gallate (EGCG). Because various catechin derivatives potently enhance these health benefits, we manipulated the extraction process with a high-temperature intervention. High-temperature-processed green tea extract (HTP-GTE) showed an elevated proportion of gallocatechin gallate (GCG) content. To investigate the preventive effects of HTP-GTE on cognitive decline, we found its neuroprotective effects against amyloid β (Aβ)-induced neurotoxicity in neurons and clarified that GCG significantly inhibited Aβ aggregation in vitro. Moreover, we showed that HTP-GTE intake attenuated several cognitive-decline phenotypes in a model mouse of Alzheimer’s disease. These beneficial effects of HTP-GTE against cognitive decline were due to the distinctive composition of the extract and suggest the possibility that HTP-GTE supplementation could attenuate cognitive decline of Alzheimer’s disease.

HTP-GTE which contains high rate of GCG inhibited Aβ aggregation in vitro and reduced Aβ in insoluble fraction in vivo.

Funding

This research was supported by grants from the Amorepacific R&D center. HTP-GTE sample was obtained from the Amorepacific R&D center.

History